• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • ResearchMatch (RM)
    • Biomarkers
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • Manage Studies
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page
Pfizer and Moderna Are Testing a Third ‘Booster’ Dose for Their COVID-19 Vaccines

Pfizer and Moderna Are Testing a Third ‘Booster’ Dose for Their COVID-19 Vaccines

by William Jester | Mar 27, 2021 | News

In an attempt to ensure the effectiveness of their COVID-19 vaccines against new variants of the novel coronavirus, both Pfizer and Moderna are testing a third booster shot of their respective two-dose vaccines. On February 25, Pfizer announced that it is studying a...
How we can use psychological principles to foster collaboration in the fight against COVID-19

How we can use psychological principles to foster collaboration in the fight against COVID-19

by William Jester | Mar 26, 2021 | Community, Covid, News

COVID-19 can be thought of as a game of chicken, except instead of driving head-on towards each other and betting the other person will swerve at the last minute, we’re going out when we should be staying home and foregoing social distancing, masks and hygiene...
Could ‘worrisome’ new COVID-19 variants undermine progress?

Could ‘worrisome’ new COVID-19 variants undermine progress?

by William Jester | Mar 26, 2021 | Community, Covid, News

As the state waits for more doses of COVID-19 vaccine to get in the pipeline, new threats of a surge in cases of the disease loom due to the emergence of worrisome variants. More than 50 cases of a variant first detected in the U.K. have been found here, according to...
Some with long-haul COVID-19 see surprisingly positive vaccine side effect

Some with long-haul COVID-19 see surprisingly positive vaccine side effect

by William Jester | Mar 25, 2021 | Community, Covid, News

In June 2020, Michelle Chason tested positive for COVID-19. Even after she felt better and had a negative test, she still experienced lingering symptoms, including brain fog, short-term memory loss, intensified acid reflux and tingling and numbness on the left side of...
How to Vaccinate Homebound Seniors? Take the Shots to Them.

How to Vaccinate Homebound Seniors? Take the Shots to Them.

by Pamela Dahlen | Mar 25, 2021 | Community, Covid, News

Millions of older Americans, chronically ill and trapped at home, pose a big challenge to inoculation efforts. Doctors are on it. At least two million Americans are homebound, a population all but invisible. Most suffer from multiple chronic conditions, but cannot get...
« Older Entries
Next Entries »

Recent Posts

  • New COVID-19 Drug Shows Greater Promise Against Resistant Viral Strains.
  • How a new library is set to transform this underserved N.J. community
  • Poll Finds Majority of New Jerseyans Give Negative Ratings to State and National Economy.
  • New NJACTS Publication
  • One Rule Change Would Help Tens of Thousands of New Jersey Families Pay for Childcare

Archives

  • 2025
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,243)
  • Covid (985)
  • CTO Events (6)
  • News (2,858)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.